New combo tackles lung cancer after standard treatment fails
NCT ID NCT06029127
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This study tested a new drug called gimistotug (BGB-A445) combined with other experimental drugs in 35 people with advanced non-small cell lung cancer who had already received standard treatments like immunotherapy and chemotherapy. The main goal was to see if the combination could shrink tumors. Researchers also monitored side effects. The study is complete, and results will help guide future treatment options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Jiangnan University South Campus
Wuxi, Jiangsu, 214122, China
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
-
Daping Hospital, Third Military Medical University
Chongqing, Chongqing Municipality, 400042, China
-
Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, 200000, China
-
Gansu Provincial Hospital
Lanzhou, Gansu, 730000, China
-
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, 150000, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450000, China
-
National Cancer Center
Goyang-si, Gyeonggi-do, 10408, South Korea
-
Severance Hospital Yonsei University Health System
Seoul, Seoul Teugbyeolsi, 03722, South Korea
-
Shanxi Provincial Cancer Hospital
Taiyuan, Shanxi, 030013, China
-
The Catholic University of Korea, St Vincents Hospital
Suwon, Gyeonggi-do, 16247, South Korea
-
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Guangzhou, Guangdong, 510405, China
-
The First Affiliated Hospital of Nanchang University Branch Donghu
Nanchang, Jiangxi, 330006, China
-
The Second Affiliated Hospital of Shandong First Medical University
Taian, Shandong, 271099, China
-
The Second Xiangya Hospital of Central South University
Changsha, Hunan, 410011, China
-
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430022, China
-
Weihai Municipal Hospital
Weihai, Shandong, 264299, China
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.